Oral Fluralaner Treatment in a Dog with Desperate Demodicosis: A Case Report

다국어 초록 (Multilingual Abstract)

A 10-year-old castrated male Shih-tzu dog presented with a history of generalized demodicosis, refractory to conventional therapy with ivermectin and amitraz for a year. The patient was also diagnosed with concurrent deep pyoderma, Malassezia dermatitis, and otitis externa. Treatment with amoxicillin-clavulanate, antifungal drugs (itraconazole, miconazole), and milbemycin oxime resulted in a good response for 90 days. Approximately 4 months later, the first relapse of demodicosis occurred and the miticidal therapy was changed to ivermectin.
Additional diagnostic tests were performed to investigate an underlying cause for the recurrence of demodicosis, and endocrinopathies and allergic dermatitis were excluded based on the results. Although ivermectin therapy was sustained for 440 days, a second relapse occurred and amitraz baths were added to the therapy. Despite this therapy, the demodicosis persisted, and the miticidal therapy was changed to oral fluralaner, which led to rapid resolution. Demodicosis did not recur again before death approximately 920 days after administration of oral fluralaner.
This case report describes the complete resolution of refractory demodicosis using oral fluralaner in a dog.

참고문헌 (Reference)

1 Koch SN, "Updates on the management of canine demodicosis" 2017 : 77-85, 2017

2 Mueller RS, "Treatment protocols for demodicosis : an evidence-based review" 15 : 75-89, 2004

3 Noli C, "Treatment of canine Old World visceral leishmaniasis : a systematic review" 16 : 213-232, 2005

4 Gassel M, "The novel isoxazoline ectoparasiticide fluralaner : selective inhibition of arthropod γ-aminobutyric acid-and L-glutamate-gated chloride channels and insecticidal/acaricidal activity" 45 : 111-124, 2014

5 Walther FM, "Safety of fluralaner chewable tablets (Bravecto™), a novel systemic antiparasitic drug, in dogs after oral administration" 7 : 87-, 2014

6 Scott DW, "Muller and Kirk’s small animal dermatology" Saunders 423-516, 2013

7 Campbell WC, "Ivermectin : a potent new antiparasitic agent" 221 : 823-828, 1983

8 Sainz Á, "Guideline for veterinary practitioners on canine ehrlichiosis and anaplasmosis in Europe" 8 : 75-, 2015

9 Wagner R, "Field efficacy of moxidectin in dogs and rabbits naturally infested with Sarcoptes spp., Demodex spp. and Psoroptes spp. mites" 93 : 149-158, 2000

10 Fourie JJ, "Efficacy of orally administered fluralaner(Bravecto™)or topically applied imidacloprid/moxidectin(Advocate®)against generalized demodicosis in dogs" 8 : 187-, 2015

11 Johnstone IP, "Doramectin as a treatment for canine and feline demodicosis" 32 : 98-103, 2002

12 Mueller RS, "Diagnosis and treatment of demodicosis in dogs and cats : clinical consensus guidelines of the World Association for Veterinary Dermatology" 31 : 5-27, 2020

13 Ferrer L., "Demodicosis: treatment of difficult and desperate cases" 108-111, 2016

14 Hensel P, "Canine atopic dermatitis : detailed guidelines for diagnosis and allergen identifica tion" 11 : 196-, 2015

15 Solano-Gallego L, "A review of canine babesiosis : the European perspective" 9 : 336-, 2016

16 Rohdich N, "A randomized, blinded, controlled and multi-centered field study comparing the efficacy and safety of Bravecto™(fluralaner)against Frontline™(fipronil)in flea-and tick-infested dogs" 7 : 83-, 2014

17 Duangkaew L, "A field trial in Thailand of the efficacy of oral fluralaner for the treatment of dogs with generalized demodicosis" 29 : 208-e74-, 2018